
Jul 4, 2026
WCG Report: Only 11% of Pharma Firms Fully Implemented AI in Clinical Trials
Running a clinical trial requires coordinating dozens of interdependent processes across multiple sites, teams, and regulatory requirements. Software in this domain addresses the full operational lifecycle: managing trial master files and site monitoring workflows, capturing and validating patient data electronically, and ensuring randomization and drug supply are correctly aligned throughout the study.
Patient-facing processes are equally critical. Collecting informed consent digitally, gathering patient-reported outcomes, and supporting remote or decentralized visit models all demand dedicated tooling. Financial management — covering site payments, patient reimbursements, and budget tracking — adds further operational complexity that generic platforms rarely handle well.
Across all of these functions, data quality and audit readiness remain constant concerns. Teams rely on automated review tools to detect anomalies, flag protocol deviations, and maintain inspection-ready documentation. Recruiting the right patients efficiently, including from underrepresented populations, is increasingly recognized as one of the most consequential factors in trial success or delay.
Tools that automate and augment the review, quality checking, anomaly detection, and real-time monitoring of clinical trial data across sites, patients, and operations.
Integrated platforms for clinical trial operations management and electronic trial master file organisation -- site monitoring, compliance tracking, document control, and inspection readiness.
Tools that digitize informed consent through multimedia content, eSignatures, comprehension checks, and audit trails, paired with telehealth capabilities for decentralized trials.
Platforms for digital collection, validation, and management of clinical trial data through electronic case report forms. Includes eSource and direct data capture from EHR systems.
Tools that manage patient payments, travel reimbursement, site payment processing, budget planning, and financial compliance across clinical trial participation.
Tools and platforms that identify, screen, and enrol eligible patients into clinical trials through automated eligibility matching against inclusion/exclusion criteria and protocol requirements -- site referral networks, patient-facing trial finders, diversity and underrepresented population targeting, pre-screening workflows, and enrolment pipeline tracking.
Tools that digitally collect patient-reported and clinician-observed outcome data in trials, extending to participant engagement, wearable integration, and decentralized data capture.
Tools that automate subject randomization, treatment allocation, and clinical drug supply chain operations -- forecasting, inventory tracking, dispensing, and returns -- across trial sites.
Tools supporting clinical research sites in managing trial execution, site startup, regulatory document organisation (ISF, eTMF), staff training, and site performance tracking.
Sponsors and CROs managing multiple sites struggle to maintain consistent oversight without a unified operational platform.
Enrolment shortfalls are the leading cause of trial delays, requiring systematic eligibility matching and pipeline visibility.
Manual monitoring processes often surface protocol deviations or data anomalies after corrective action is no longer practical.
Incomplete or disorganised trial master files create significant risk when regulatory agencies request on-site or remote inspections.
Remote consent processes must satisfy regulatory requirements for comprehension verification, audit trails, and version control.
Poor forecasting and inventory coordination lead to expired product, site shortfalls, and costly emergency resupply operations.
Large-scale trials require integrated platforms to coordinate site activation, document management, randomization, and central monitoring simultaneously.
Shifting from 100% source data verification to targeted oversight depends on automated data review and real-time site metrics.
Research sites running several protocols need tools to track regulatory documents, staff training, and visit schedules without duplication of effort.
When participants cannot attend in-person visits, eConsent, ePRO, and telehealth tools become operationally necessary rather than optional.
Trials with interim analysis and arm modifications need randomization systems capable of handling real-time protocol adjustments and supply reallocation.
Before filing or inspection, sponsors must verify that all essential documents are present, properly indexed, and audit-trail compliant.



Trial data must conform to CDISC and other standards before regulatory submission and agency review.
Safety events captured during trials feed directly into pharmacovigilance and regulatory safety reporting workflows.
EHR-sourced data and real-world patient records increasingly intersect with eSource and direct data capture strategies.
External patient population data informs trial feasibility, site selection, and recruitment targeting decisions.
GCP compliance, audit management, and quality systems overlap with trial documentation and inspection readiness processes.

Jul 4, 2026
WCG Report: Only 11% of Pharma Firms Fully Implemented AI in Clinical Trials

Jun 30, 2026
Towards an EU clinical trials competitiveness initiative: restoring Europe's edge

Jun 22, 2026
ICON Selects Microsoft to Power AI-enabled Clinical Development

Jun 16, 2026
Faculty Introduces the Frontier Life Sciences Developer Studio, Giving Clinical Trial Teams a Faster Path to Simulation-Driven Decision Intelligence

Jun 14, 2026
How Astellas’ AI-Driven Clinical Overhaul and KRAS Bet Will Impact Astellas Pharma (TSE:4503) Investors

Jun 12, 2026
Astellas taps AI to reshape clinical programs as rising stars emerge